LI
IMUX icon

Leap Investments’s Immunic IMUX Stock Holding History

Leap Investments’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$139K Buy
+1,150
New +$117K 0.09% 333

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Leap Investments's IMUX Position: Q2 2020 in Review

Leap Investments opened a new position in Immunic (IMUX) in Q2 2020: 1,150 shares worth $139K. The stake represents 0.09% of the portfolio and ranks #333 among its holdings.

51 funds tracked by Wall St. Rank hold IMUX as of Q2 2020.

  • Leap Investments held 1,150 shares of Immunic worth $139K as of Q2 2020.
  • Immunic was a new Leap Investments position in Q2 2020.
  • Immunic made up 0.09% of Leap Investments's portfolio in Q2 2020, its #333 holding.
  • 51 funds tracked by Wall St. Rank held Immunic as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.